Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Elixir CapitalBOM:531278 -3.73%55 EBITDA Margin % is 825.41% as of Mar. 2026, which is 1077% above its 10-year median of 70.14. GuruFocus rates BOM:531278 with a GF Score™ of 55/100. The stock has 6 warning signs investors should review. Among 671 Capital Markets companies, Elixir Capital ranks better than 51.71% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Elixir Capital's EBITDA for the
three
months ended in Mar. 2026 was ₹-95.0 Mil. Elixir Capital's Revenue for the
three
months ended in Mar. 2026 was ₹-11.5 Mil. Therefore, Elixir Capital's EBITDA margin for the quarter that ended in Mar. 2026 was 825.41%.
Elixir Capital (BOM:531278) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Elixir Capital EBITDA Margin % Related Terms
Elixir Capital EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Elixir Capital's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:531278 vs MS, GS, SCHW: EBITDA Margin % Comparison
For the Capital Markets subindustry, Elixir Capital's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Elixir Capital EBITDA Margin % vs Capital Markets Industry
For the Capital Markets industry and Financial Services sector, Elixir Capital's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Elixir Capital's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Elixir Capital (BOM:531278) has a EBITDA Margin % of 825.41% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Elixir Capital and its competitors. This is 1077% above median its historical median of 70.14. According to the industry distribution chart, Elixir Capital ranks #324 out of 671 companies in the Capital Markets industry, placing it in the top 48.3%.
Is Elixir Capital's EBITDA Margin % too high?
Elixir Capital's current EBITDA Margin % of 825.41% is 1077% above median its 10-year median of 70.14. The Capital Markets industry median EBITDA Margin % is 22.10. Elixir Capital's value of 825.41% is 3634.9% above this industry median. Based on the distribution chart, Elixir Capital ranks #324 out of 671 companies in the Capital Markets industry, which is above the industry midpoint. Overall, Elixir Capital has a GF Score™ of 55/100, reflecting its overall financial health beyond just this single metric.
How does Elixir Capital's EBITDA Margin % compare to MS and GS?
According to the Capital Markets industry distribution chart, Elixir Capital ranks #324 out of 671 companies for EBITDA Margin %. This puts Elixir Capital in the upper half of its industry. The industry median EBITDA Margin % is 22.10. Elixir Capital's value of 825.41% is 3634.9% above this benchmark. While the company's 10-year median is 70.14 vs. the industry median of 22.10, Elixir Capital has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Capital Markets company?
The median EBITDA Margin % among Capital Markets companies is 22.10, based on 671 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Elixir Capital's current EBITDA Margin % of 825.41% is 3634.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Elixir Capital and its competitors. For the Capital Markets industry, the median EBITDA Margin % is 22.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Elixir Capital's current EBITDA Margin % is 825.41%, which is 1077% above median its own 10-year median of 70.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Elixir Capital stock overvalued right now?
Elixir Capital (BOM:531278) has a current EBITDA Margin % of 825.41%. The current EBITDA Margin % is 825.41%, which is 1077% above median its 10-year median of 70.14 and 3634.9% above the Capital Markets industry median of 22.10. Elixir Capital's overall GF Score™ is 55/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Elixir Capital (BOM:531278), the current EBITDA Margin % is 825.41% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Elixir Capital Ltd is a financial service holding company. It is engaged in stock broking, portfolio management, depository services, trading, and investment in securities.
55GF Score
Get the complete analysis for BOM:531278
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:531278 has been successfully added to your 
